Expression of a Hypoglycosylated Form of CD86 (B7-2) on Human T Cells with Altered Binding Properties to CD28 and CTLA-4

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4799-4805

  Höllsberg, Per ^a,b   Scholz, Christian ^b,c   Anderson, David E ^b   Greenfield, Edward A ^b   Kuchroo, Vijay K ^b   Freeman, Gordon J ^b   Hafler, David A ^b  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; CD28 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CELL LINE; CHO CELL; GLYCOSYLATION; HAMSTER; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CHO CELLS; CLONE CELLS; CRICETINAE; GLYCOSYLATION; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; T-LYMPHOCYTE SUBSETS;

EID: 0031573078     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. June, C., J. Bluestone, L. Nadler, and C. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
2. Harding, F., J. McArthur, J. Gross, D. Raulet, and J. Allison. 1992. CD28 mediated signalling costimulates murine T cells and prevents the induction of anergy in T cell clones. Nature 356:607.
3. Mueller, D., and M. Jenkins. 1995. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7:375.
4. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
5. Linsley, P., W. Brady, L. Grosmaire, A. Aruffo, N. Damle, and J. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
6. Lindsten, T., C. June, J. Ledbetter, G. Stella, and C. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T-cell activation pathway. Science 244:339.
7. Umlauf, S., B. Beverly, O. Lantz, and R. Schwartz. 1995. Regulation of IL-2 gene expression by CD28 costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNA are regulated with complex kinetics. Mol. Cell. Biol. 15:3197.
8. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
9. Linsley, P., W. Brady, M. Urnes, L. Grosmaire, N. Damle, and J. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
10. Lindsten, T., K. Lee, E. Harris, B. Petryniak, N. Craighead, P. Reynolds, D. Lombard, G. Freeman, L. Nadler, G. Gray, C. Thompson, and C. June. 1993. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151:3489.
11. Freeman, G., D. Lombard, C. Gimmi, S. Brod, K. Lee, J. Laning, D. Hafler, M. Dorf, G. Gray, H. Reiser, C. June, C. Thompson, and L. Nadler. 1992. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation: expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149:3795.
12. Tivol, E., F. Borriello, A. Schweitzer, W. Lynch, J. Bluestone, and A. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
13. Waterhouse, P., J. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. Lee, C. Thompson, H. Griesser, and T. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
14. Krummel, M., and J. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
15. Walunas, T., D. Lenschow, C. Bakker, P. Linsley, G. Freeman, J. Green, C. Thompson, and J. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
16. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
17. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
18. Gribben, J., G. Freeman, V. Boussiotis, P. Rennert, C. Jellis, E. Greenfield, M. Barber, V. Restivo, X. Ke, G. Gray, and L. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.
19. Linsley, P., J. Greene, W. Brady, J. Bajorath, J. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
20. Morton, P., X.-T. Fu, J. Stewart, K. Giacoletto, S. White, C. Leysath, R. Evans, J.-J. Shieh, and R. Karr. 1996. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156:1047.
21. Ellis, J. H., M. N. Burden, D. V. Vinogradov, C. Linge, and J. S. Crowe. 1996. Interactions of CD80 and CD86 with CD28 and CTLA4. J. Immunol. 156:2700.
22. Kariv, I., A. Truneh, and R. W. Sweet. 1996. Analysis of the site of interaction of CD28 with its counterreceptors CD80 and CD86 and correlation with function. J. Immunol. 157:29.
23. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
24. + T cells and induce similar pattern of cytokines secretion in vitro. Int. Immunol. 7:891.
25. Natesan, M., Z. Razi-Wolf, and H. Reiser. 1996. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J. Immunol. 165:2783.
26. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
27. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
28. Freeman, G., V. Boussiotis, A. Anumanthan, G. Bernstein, X.-Y. Ke, P. Rennert, G. Gray, J. Gribben, and L. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
29. Gajewski, T. 1996. B7-1 but not B7-2 efficiently costimulates CD8 T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
30. Matulonis, U., C. Dosiou, G. Freeman, C. Lamont, P. Mauch, L. Nadler, and J. Griffin. 1996. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. J. Immunol. 156:1126.
31. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
32. Höllsberg, P., W. E. J. Weber, F. Dangond, V. Batra, A. Sette, and D. A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 92:4036.
33. Scholz, C., G. J. Freeman, E. A. Greenfield, D. A. Hafler, and P. Höllsberg. 1996. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation. J. Immunol. 157:2932.
34. Höllsberg, P., L. J. Ausubel, and D. A. Hafler. 1994. Human T cell lymphotropic virus type I-induced T cell activation: resistance to TGF-β1-induced suppression. J. Immunol. 153:566.
35. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein: dye binding. Anal. Biochem. 72:248.
36. Brod, S., M. Purvee, D. Benjamin, and D. Hafler. 1990. T-T cell interactions are mediated by adhesion molecules. Eur. J. Immunol. 20:2239.
37. Bouchonnet, F., D. Lecossier, A. Bellocq, I. Hamy, and A. Hance. 1994. Activation of T cells by previously activated T cells. J. Immunol. 153:1921.
38. Wucherpfennig, K. W., P. Höllsberg, J. H. Richardson, D. Benjamin, and D. A. Hafler. 1992. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc. Natl. Acad. Sci. USA 89:2110.
39. Tao, M.-H., and S. Morrison. 1989. Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2595.
40. Greenfield, E. A., E. Howard, T. Paradis, K. Nguyen, F. Benasso, P. McLean, P. Höllsberg, G. Davis, D. A. Hafler, A. H. Sharpe, G. J. Freeman, and V. K. Kuchroo. 1997. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding. J. Immunol. 158:2025.